Logos Global Management LP Day One Biopharmaceuticals, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$11.74 - $14.47 $7.63 Million - $9.41 Million
650,000 New
650,000 $7.76 Million
Q1 2022

May 16, 2022
SELL
$9.12 - $17.47 $338,069 - $647,595
-37,069 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$15.65 - $26.33 $234,750 - $394,950
-15,000 Reduced 28.81%
37,069 $624,000
Q3 2021

Nov 15, 2021
BUY
$20.0 - $27.92 $300,000 - $418,800
15,000 Added 40.47%
52,069 $2.8 Million
Q2 2021

Aug 16, 2021
BUY
$19.0 - $23.69 $704,311 - $878,164
37,069 New
37,069 $844,000

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email